BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,286,818 | -12.7% | 193,079 | +5.4% | 0.01% | -14.3% |
| Q2 2023 | $8,343,226 | +10.7% | 183,126 | -1.5% | 0.01% | +7.7% |
| Q1 2023 | $7,537,959 | -28.2% | 185,847 | -9.8% | 0.01% | -27.8% |
| Q4 2022 | $10,502,533 | +81.3% | 206,053 | +91.6% | 0.02% | +63.6% |
| Q3 2022 | $5,792,000 | -15.7% | 107,530 | +0.6% | 0.01% | -15.4% |
| Q2 2022 | $6,867,000 | -26.0% | 106,894 | -10.7% | 0.01% | -13.3% |
| Q1 2022 | $9,286,000 | -23.8% | 119,761 | -15.6% | 0.02% | -21.1% |
| Q4 2021 | $12,186,000 | +4.0% | 141,957 | -2.5% | 0.02% | 0.0% |
| Q3 2021 | $11,715,000 | +0.9% | 145,650 | +1.0% | 0.02% | 0.0% |
| Q2 2021 | $11,607,000 | -6.3% | 144,192 | -1.8% | 0.02% | -13.6% |
| Q1 2021 | $12,385,000 | +22.0% | 146,858 | +16.1% | 0.02% | +15.8% |
| Q4 2020 | $10,149,000 | -4.6% | 126,483 | -4.4% | 0.02% | -17.4% |
| Q3 2020 | $10,641,000 | -19.2% | 132,315 | -13.5% | 0.02% | -23.3% |
| Q2 2020 | $13,170,000 | +1.5% | 152,956 | -4.3% | 0.03% | -11.8% |
| Q1 2020 | $12,978,000 | -12.9% | 159,839 | -10.3% | 0.03% | +13.3% |
| Q4 2019 | $14,896,000 | +276.8% | 178,145 | +294.2% | 0.03% | -55.9% |
| Q3 2019 | $3,953,000 | -2.9% | 45,188 | -9.1% | 0.07% | -2.9% |
| Q2 2019 | $4,070,000 | -10.7% | 49,693 | -11.4% | 0.07% | -13.6% |
| Q1 2019 | $4,559,000 | -1.7% | 56,061 | -20.4% | 0.08% | -14.7% |
| Q4 2018 | $4,636,000 | -51.5% | 70,423 | -43.2% | 0.10% | -44.8% |
| Q3 2018 | $9,564,000 | -11.6% | 124,063 | -15.3% | 0.17% | -16.5% |
| Q2 2018 | $10,818,000 | +6.0% | 146,499 | -6.6% | 0.21% | +5.6% |
| Q1 2018 | $10,202,000 | -12.8% | 156,845 | -13.4% | 0.20% | -11.0% |
| Q4 2017 | $11,703,000 | -0.2% | 181,043 | -3.1% | 0.22% | -3.9% |
| Q3 2017 | $11,723,000 | +16.9% | 186,822 | +12.7% | 0.23% | +14.6% |
| Q2 2017 | $10,032,000 | +115.5% | 165,708 | +84.6% | 0.20% | +111.7% |
| Q1 2017 | $4,655,000 | +61.5% | 89,757 | +38.1% | 0.09% | +59.3% |
| Q4 2016 | $2,882,000 | -13.7% | 64,986 | -7.4% | 0.06% | -14.5% |
| Q3 2016 | $3,341,000 | -5.4% | 70,175 | -10.2% | 0.07% | -6.8% |
| Q2 2016 | $3,533,000 | -23.1% | 78,140 | -30.2% | 0.07% | -37.8% |
| Q1 2016 | $4,596,000 | +16.6% | 111,886 | +8.3% | 0.12% | +16.7% |
| Q4 2015 | $3,940,000 | -6.4% | 103,289 | -19.4% | 0.10% | -6.4% |
| Q3 2015 | $4,211,000 | -64.4% | 128,162 | -24.2% | 0.11% | -65.9% |
| Q2 2015 | $11,831,000 | -28.5% | 169,186 | -30.0% | 0.32% | -32.6% |
| Q1 2015 | $16,554,000 | -23.5% | 241,659 | -18.2% | 0.48% | -25.2% |
| Q4 2014 | $21,640,000 | +0.4% | 295,272 | -1.7% | 0.64% | -2.5% |
| Q3 2014 | $21,552,000 | -0.5% | 300,288 | +0.2% | 0.65% | +0.3% |
| Q2 2014 | $21,658,000 | -4.2% | 299,565 | -2.5% | 0.65% | -8.8% |
| Q1 2014 | $22,601,000 | +7.2% | 307,167 | +1.3% | 0.71% | +4.9% |
| Q4 2013 | $21,085,000 | +9.9% | 303,150 | +3.8% | 0.68% | -0.1% |
| Q3 2013 | $19,186,000 | -3.6% | 292,064 | +1.6% | 0.68% | -8.2% |
| Q2 2013 | $19,907,000 | – | 287,375 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |